Number of Shares
1.47 Mil
Current Holdings Value*
$103.03 Mil
% of Portfolio
0.22%
Total Estimate Gain
$76.24 Mil
% of Total Estimate Gain
56.89%

Vanguard Health Care Fund's Cytokinetics Inc Holding Summary

As of 2024-03-31, Vanguard Health Care Fund held 1.47 Mil shares of Cytokinetics Inc(CYTK), totaling $103.03 Mil. This investment constitutes 0.22% of their stock portfolio, and Vanguard Health Care Fund now holds 1.41% of the outstanding Cytokinetics Inc(CYTK) stock.

The initial trade took place in 2022Q2. And since then Vanguard Health Care Fund has made 4 purchases of CYTK, at an average price of $40.19, for a total of 3.33 Mil shares. In addition, there have been 2 sales at an average price of $65.70 for 1.86 Mil shares. Based on historical transaction data and CYTK's current price of $59.69, Vanguard Health Care Fund's estimated gain on his CYTK holdings is $76.24 Mil, reflecting a 56.89% gain to date.

Vanguard Health Care Fund CYTK ($59.69) Holding Chart

Vanguard Health Care Fund CYTK ($59.69) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1